Chronic hyperglycemia is thought to be the primary cause of diabetic retinopathy, this hypothesis was supported by diabetes Control and Complications Trial (DCCT), which found that intensive insulin therapy, achieving a mean HbA1 % of 7.9 %, reduce the incidence of retinopathy by as much as 76% compared with conventional therapy. Here, INS is linked to diabetes mellitus.